Yishan (Peter) Li’s Post

Lots of great things happening at UBC; let's connect at Asembia and talk about your patient access needs. -https://hubs.li/Q02rj16m0 #PatientsFirst #Asembia24 #Pharma #PatientSupport

Dr. Jörg Duschmalé, board member of Roche, with a 128-year-old family business ownership, presented at our recent High Performance Board sessions IMD. Learn more about the program here - https://bit.ly/49XnCfP As the youngest board member at Roche, one of the largest pharmaceutical companies globally, Dr. Duschmalé emphasised that the governance structure, with the founder’s family ownership, is a key success factor. In a challenging environment, such as an aging population and a growing burden of chronic diseases, family ownership allows for a longer-term approach, rather than focusing on short-term gains. “It is easy to cut R&D, but with our transgenerational view, we choose to do the right things now within the company for the future.” In response to a question on how to prepare for being a board member in family businesses, Dr. Duschmalé expressed appreciation for a less predefined process. It gave him flexibility to approach responsibilities in various ways, especially considering his background as a chemist. Without this freedom, he might have felt constrained by the family legacy. “Be honest, be humble, and be yourself.” With this philosophy, Dr. Duschmalé’s insights illuminate the essence of serving as a board member across diverse governance environments. #imdimpact #highperformanceboards #imdboardcenter #corporategovernance #familybusiness 

Science, research and manufacturing in Australia. AstraZeneca CEO, Pascal Soriot, ANZ CEO, Ben McDonald, and Director of Corporate Affairs, Penny George, met with the Hon. Ed Husic MP, Australian Minister for Industry and Science, to discuss science, research and manufacturing in Australia. We discussed the breadth of AstraZeneca’s presence in Australia, from clinical trials through to manufacturing. We also explored how greater collaboration between industry and government could shape the future landscape of science, research and manufacturing and advance better health for Australians.  Through concerted efforts together we can continue to unlock the power of what science can do. 

Vietnam’s Ministry of Health presented significant amendments to the pharmaceutical law to the National Assembly in June 2024. The 2016 Pharmaceutical Law, which succeeded the 2005 law, initially provided a transparent legal foundation for the pharmaceutical industry and aligned with global standards. However, some aspects of the law have become outdated over the past eight years. The proposed revisions aim to ensure public access to quality, affordable medicines, resolve legal and institutional challenges, and guarantee medicine availability for disease prevention and emergencies. Read more: https://lnkd.in/gbpdTAnM

In 1849, Charles Pfizer and his cousin, Charles Erhart, used their expertise in chemistry and confection to develop a medicine that was actually palatable to the patients it was meant to treat. It worked, and that first breakthrough helped launch nearly two centuries of medical milestones. For the past 175 years, Pfizer has been challenging itself to not only stay the course but to 'outdo yesterday' by continuing to create breakthroughs that change patients' lives for the better. Learn more about our history and where we hope to break through to next: https://lnkd.in/e4i6rFkg #PFEColleague

In 1849, Charles Pfizer and his cousin, Charles Erhart, used their expertise in chemistry and confection to develop a medicine that was actually palatable to the patients it was meant to treat. It worked, and that first breakthrough helped launch nearly two centuries of medical milestones. For the past 175 years, Pfizer has been challenging itself to not only stay the course but to 'outdo yesterday' by continuing to create breakthroughs that change patients' lives for the better. Learn more about our history and where we hope to break through to next: https://lnkd.in/e4i6rFkg #PFEColleague

In 1849, Charles Pfizer and his cousin, Charles Erhart, used their expertise in chemistry and confection to develop a medicine that was actually palatable to the patients it was meant to treat. It worked, and that first breakthrough helped launch nearly two centuries of medical milestones. For the past 175 years, Pfizer has been challenging itself to not only stay the course but to 'outdo yesterday' by continuing to create breakthroughs that change patients' lives for the better. Learn more about our history and where we hope to break through to next: https://lnkd.in/e4i6rFkg #PFEColleague

In 1849, Charles Pfizer and his cousin, Charles Erhart, used their expertise in chemistry and confection to develop a medicine that was actually palatable to the patients it was meant to treat. It worked, and that first breakthrough helped launch nearly two centuries of medical milestones. For the past 175 years, Pfizer has been challenging itself to not only stay the course but to 'outdo yesterday' by continuing to create breakthroughs that change patients' lives for the better. Learn more about our history and where we hope to break through to next: https://lnkd.in/e4i6rFkg #PFEColleague

In 1849, Charles Pfizer and his cousin, Charles Erhart, used their expertise in chemistry and confection to develop a medicine that was actually palatable to the patients it was meant to treat. It worked, and that first breakthrough helped launch nearly two centuries of medical milestones. For the past 175 years, Pfizer has been challenging itself to not only stay the course but to 'outdo yesterday' by continuing to create breakthroughs that change patients' lives for the better. Learn more about our history and where we hope to break through to next: https://lnkd.in/e4i6rFkg #PFEColleague

In 1849, Charles Pfizer and his cousin, Charles Erhart, used their expertise in chemistry and confection to develop a medicine that was actually palatable to the patients it was meant to treat. It worked, and that first breakthrough helped launch nearly two centuries of medical milestones. For the past 175 years, Pfizer has been challenging itself to not only stay the course but to 'outdo yesterday' by continuing to create breakthroughs that change patients' lives for the better. Learn more about our history and where we hope to break through to next: https://lnkd.in/e4i6rFkg #PFEColleague